Faculty, Staff and Student Publications
Language
English
Publication Date
9-1-2025
Journal
Nature Medicine
DOI
10.1038/s41591-025-03895-1
PMID
40691367
PMCID
PMC12443589
PubMedCentral® Posted Date
7-21-2025
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Recommended Citation
Nassiri, Farshad; Patil, Vikas; Yefet, Leeor S; et al., "Author Correction: Oncolytic Dnx-2401 Virotherapy Plus Pembrolizumab in Recurrent Glioblastoma: A Phase 1/2 Trial" (2025). Faculty, Staff and Student Publications. 5651.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5651
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons
Comments
This corrects the article "Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial" in volume 29 on page 1370.